SCHEMBL7429665

SCHEMBL7429665

O=C(O)Cc1ccc2nc(Nc3cccc(F)c3)oc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
KDM4E B2RXH2 2/20 0.53
HDAC6 Q9UBN7 4/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
ALDH1A1 P00352 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
GAA P10253 2/20 0.43
PKM P14618 1/20 0.43
TP53 P04637 1/20 0.41
IL6 P05231 1/20 0.41
STAT3 P40763 1/20 0.41
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4D Q08499 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2437918 0.88 NPC1 (0.56) NPC1RAB9ASMN1; SMN2HDAC6HDAC7
SCHEMBL7659834 0.82 KDM4E (0.52) NPC1RAB9ASMN1; SMN2KDM4EHDAC6
SCHEMBL31430498 0.81 GAA (0.52) KDM4EALDH1A1GAAIL6STAT3
SCHEMBL6614738 0.80 HDAC6 (0.53) NPC1RAB9ASMN1; SMN2HDAC6ALDH1A1
SCHEMBL11640477 0.80 CSNK1D (0.49) NPC1RAB9ASMN1; SMN2ALDH1A1NPSR1
SCHEMBL2432317 0.80 ITGA4 (0.57) ITGA4ITGB1GALK1
SCHEMBL11637058 0.80 PSEN1 (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1NPSR1
SCHEMBL14626860 0.79 NPC1 (0.54) NPC1RAB9ASMN1; SMN2HDAC6ALDH1A1
SCHEMBL6593703 0.78 HDAC6 (0.62) NPC1RAB9ASMN1; SMN2KDM4EHDAC6
SCHEMBL31430606 0.77 GAA (0.55) KDM4EALDH1A1GAAIL6STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1133484-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS AstraZeneca AB (SE) 2001-09-19 EP disclosed
WO-2000005223-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS ASTRAZENECA AB (SE) 2000-02-03 WO disclosed